查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988269

心理健康筛检市场：以数位筛检工具、临床筛检工具、纸本工具和穿戴式筛检工具划分－2026-2032年全球市场预测

Mental Health Screening Market by Digital Screening Tools, Clinical Screening Tools, Paper-Based Tools, Wearable Screening Tools - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心理健康筛检市场价值将达到 21.8 亿美元，到 2026 年将成长至 23.7 亿美元，到 2032 年将达到 39.3 亿美元，复合年增长率为 8.75%。

主要市场统计数据
基准年 2025 21.8亿美元
预计年份：2026年 23.7亿美元
预测年份 2032 39.3亿美元
复合年增长率 (%) 8.75%

这是一本权威的心理健康筛检指南。它揭示了各种筛检方法、引入这些方法的理由以及塑造现代筛检实践的操作重点。

心理健康筛检在临床实践、公共卫生政策和数位创新之间占据着至关重要的地位。随着心理健康问题日益普遍的受到各医疗机构的关注，筛检工具和管道在识别可能需要评估或介入的个体方面发挥关键作用。本导言整体情况了该领域，说明了日常使用的工具、分发管道以及实施环境，为读者在阅读更详细的分析章节之前提供一致的指南。

数位创新、严格的监管和持续的监测如何融合，将筛检从一次性测试重新定义为全面的、情境化的照护路径。

心理健康筛检领域正经历着一场变革性的转变，这主要得益于技术、临床实践和人口需求的融合。人工智慧 (AI) 和机器学习正从实验性的研究对象转变为筛检工作流程中的实用组成部分，它们能够实现更高级的模式识别和自适应评估逻辑，从而提高筛检的敏感性并减轻受检者的负担。同时，以用户为中心的设计原则和行动优先的开发理念正在提高自助式筛检工具的使用率和完成率，使其应用范围超越了传统的诊所环境。

2025 年关税变化和贸易政策调整为整个筛检生态系统带来了供应链复杂性的增加，促使过程采取策略性采购、在地化和风险管理措施。

2025年的关税调整和贸易政策变化为全球心理健康筛检生态系统中使用的设备和组件供应链带来了营运摩擦。对于生物感测器设备和某些智慧型手錶等硬体依赖产品，进口关税和海关程序的变化迫使供应商重新评估其策略，製造商和经销商也被迫考虑替代采购和区域组装方案。这些营运应对措施正在影响临床机构和消费管道的采购计划和库存管理。

详细的细分概述，将数位、临床、纸本和穿戴式筛检方法与实际实施、检验和工作流程影响联繫起来。

細項分析揭示了不同工具分类如何影响使用者参与流程、临床工作流程和检验要求。基于数位筛检工具，该领域涵盖人工智慧工具、行动应用程式和网路平台。人工智慧工具进一步包括机器学习模型和自然语言处理（NLP）聊天机器人，而行动应用程式则分为混合应用程式和原生应用程式。这一数位层需要严格的模型可解释性和持续的效能监控，机器学习流程、互动式代理和应用程式架构之间的差异决定了整合深度、使用者体验和监管路径。

美洲、欧洲、中东和非洲以及亚太地区的区域采用驱动因素和细微的监管差异，塑造了在地化、检验和部署策略。

区域趋势对推广路径、监管和商业化策略有显着影响。在美洲，成熟的医疗基础设施、更清晰的数位医疗服务报销标准以及完善的临床网络，都为数位筛检工具快速整合到基层医疗和专科医生的工作流程中提供了支持。对互通性和大规模试验计画的投入，促进了供应商和医疗系统之间的合作，同时，隐私和资料保护标准也在不断发展，力求在创新与病患权益之间取得平衡。

跨学科技术供应商、设备製造商、临床研究中心和策略合作伙伴如何塑造检验标准、整合路径和推广动能。

关键企业和机构参与者正在塑造心理健康筛检领域的创新步伐和标准。专注于人工智慧和行动开发的科技供应商正在加速提升自适应评估、互动式介面和安全数据管道等相关能力。设备製造商正在提高感测器的精度和能效，以支持被动监测；同时，临床服务机构和学术中心也在不断累积检验和最佳实践，以促进临床应用。

领导者应采取切实可行的策略重点，将检验的筛检成果转化为扩充性、互通性、具有文化适应性的照护路径，并建立健全的管治。

致力于将筛检创新转化为持久影响的产业领导者应优先考虑一系列综合策略行动。首先，投资严格的临床检验和透明的模型管治，以确保工具在不同目标族群中有效发挥作用。这包括前瞻性检验研究和减少偏差的考虑。其次，从一开始就将互通性纳入设计考量，以实现与电子健康记录 (EHR) 和护理管理平台的无缝集成，从而将筛检结果整合到临床决策和转诊流程中。

结合相关人员访谈、技术评估和文献整合的严谨混合方法研究框架，能够产生可操作和可复製的见解。

本研究采用混合方法，将与主要相关人员的直接访谈与二手文献分析相结合，以形成平衡且可操作的观点。关键投入包括对临床医生、技术开发人员、设备製造商和采购经理进行结构化访谈，以了解实际操作、挑战和推广应用的驱动因素。这些定性访谈用于主题分析、最佳实践识别和推广应用障碍识别。

一项明确的整合，强调了将创新与检验、管治和区域策略相结合的必要性，以将筛检的进步转化为切实的临床效益。

总之，由于数位科技的进步、法规环境的日趋成熟以及临床工作流程的不断演进，心理健康筛检正处于转折点。该领域正从单一工具转向一个整合人工智慧评估、行动互动、临床医生主导的评估和被动监测的生态系统。虽然这些整合方法有望实现更早的发现和更个人化的护理，但它们也需要严格的检验、负责任的资料管治和精心设计的实施策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 数位筛检工具在心理健康筛检市场的应用

  • 人工智慧驱动的工具
    • 机器学习模型
    • 自然语言处理聊天机器人
  • 行动应用
    • 混合应用
    • 原生应用
  • 网路平台

第九章 临床筛检工具在心理健康筛检市场的应用

  • 临床医师访谈
    • 结构化面试
    • 非结构化访谈
  • 自填式问卷
    • 焦虑调查问卷
    • 忧郁症调查问卷

第十章：印刷媒体工具在心理健康筛检市场的应用

  • 清单格式
  • 问卷格式

第十一章 穿戴式筛检工具在心理健康筛检市场的应用

  • 生物感测器设备
  • 智慧型手錶

第十二章 心理健康筛检市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 心理健康筛检市场：按群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 心理健康筛检市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国心理健康筛检市场

第十六章：中国心理健康筛检市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AbleTo, Inc.
  • Happify Health, Inc.
  • Headspace Health, Inc.
  • Lyra Health, Inc.
  • Modern Health, Inc.
  • NeuroFlow Holdings, Inc.
  • Quartet Health, Inc.
  • SilverCloud Health Limited
  • Spring Health, Inc.
  • Talkspace, Inc.
Product Code: MRR-6969F1FC5B3B

The Mental Health Screening Market was valued at USD 2.18 billion in 2025 and is projected to grow to USD 2.37 billion in 2026, with a CAGR of 8.75%, reaching USD 3.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.18 billion
Estimated Year [2026] USD 2.37 billion
Forecast Year [2032] USD 3.93 billion
CAGR (%) 8.75%

An authoritative orientation to mental health screening that clarifies modalities, deployment contexts, and the operational priorities shaping modern screening practice

Mental health screening occupies a pivotal place at the intersection of clinical practice, public health policy, and digital innovation. As the prevalence of mental health concerns continues to attract attention across care settings, screening instruments and delivery channels act as the first line of identification for individuals who may require assessment or intervention. This introduction frames the sector by describing the instruments in routine use, the channels that deliver them, and the operational contexts in which they are deployed, offering readers a coherent orientation before deeper analytical sections.

Over recent years, screening modalities have diversified beyond traditional clinician-led assessments to include digital interfaces, wearable biosensors, and hybrid workflows that blend remote and in-person evaluation. These shifts have altered both the patient experience and clinical pathways, embedding screening earlier in care journeys and enabling real-time data capture. Moreover, changes in reimbursement norms and regulatory expectations are shaping how tools are validated and adopted in practice.

This section sets out the foundational terminology and clarifies the distinctions among digital screening tools, clinician-administered instruments, paper-based formats, and wearable technologies. It also highlights the importance of interoperability, data privacy, and user experience, which together determine uptake and utility. By establishing this baseline, the reader gains a structured lens through which subsequent insights and recommendations can be understood and applied.

How digital innovation, regulatory rigor, and continuous monitoring are converging to redefine screening from episodic tests to integrated, context-aware care pathways

The landscape of mental health screening is undergoing transformative shifts driven by convergence of technology, clinical practice, and population-level demand. Artificial intelligence and machine learning have moved from experimental curiosities to pragmatic components of screening workflows, enabling sophisticated pattern recognition and adaptive assessment logic that improves sensitivity and reduces respondent burden. At the same time, user-centric design principles and mobile-first development have improved engagement and completion rates for self-administered tools, broadening reach beyond traditional clinic walls.

Concurrently, regulatory scrutiny and data governance frameworks have intensified, prompting vendors and health systems to prioritize explainability, validation against clinical standards, and secure management of sensitive health information. This has accelerated the adoption of privacy-preserving analytics and federated learning approaches that balance insight generation with patient confidentiality. Interoperability standards and integration with electronic health records have also progressed, allowing screening outputs to flow into clinical workflows and inform care escalation more reliably.

Finally, wearables and biosensor technologies are enabling passive and continuous monitoring paradigms that complement episodic screening, while clinician workflows are adapting to hybrid models that blend digital triage with focused in-person evaluation. Together, these trends signify a structural shift from isolated screening events to continuous, context-aware systems that support early identification and timely intervention.

How 2025 tariff shifts and trade policy adjustments created supply chain complexity and prompted strategic sourcing, localization, and risk management responses across screening ecosystems

Tariff changes and trade policy adjustments in 2025 have introduced operational friction across global supply chains for devices and components used in mental health screening ecosystems. For hardware-dependent products such as biosensor devices and certain smart watches, alterations in import duties and customs procedures have led to recalibrated supplier strategies, prompting manufacturers and distributors to evaluate alternative sourcing and regional assembly options. These operational responses have implications for procurement timelines and inventory management across clinical and consumer-facing channels.

Beyond hardware, shifts in trade policy have affected the distribution of software-enabled devices by altering the economics of cross-border service agreements, licensing arrangements, and the movement of embedded components. Organizations have responded by refining contractual terms, increasing emphasis on localized support capabilities, and exploring regional partnerships to mitigate exposure to tariff volatility. These adaptations have also catalyzed conversations about product modularity and localization of manufacturing processes to preserve supply continuity.

Importantly, stakeholders are prioritizing risk management and scenario planning to minimize service interruptions and maintain compliance with evolving import/export requirements. Health systems and vendors alike are using these policy-induced pressures as a catalyst to streamline procurement practices, diversify supplier bases, and strengthen contractual protections, ensuring continuity of screening services amid an unpredictable trade environment.

A nuanced segmentation overview connecting digital, clinical, paper, and wearable screening modalities to practical implementation, validation, and workflow implications

Segmentation analysis reveals how different tool classes shape user journeys, clinical workflows, and validation needs. Based on Digital Screening Tools, the field includes AI-Powered Tools, Mobile Applications, and Web Platforms; AI-Powered Tools further encompass Machine Learning Models and NLP Chatbots while Mobile Applications divide into Hybrid Apps and Native Apps. This digital tier demands rigorous model explainability and continuous performance monitoring, and the distinctions among machine learning pipelines, conversational agents, and app architectures determine integration depth, user experience, and regulatory pathways.

Based on Clinical Screening Tools, modalities are organized into Clinician Interview and Self-Report Questionnaire; Clinician Interview splits into Structured Interviews and Unstructured Interviews, whereas Self-Report Questionnaire separates into Anxiety Questionnaires and Depression Questionnaires. Structured interviews provide standardized diagnostic scaffolding that supports reproducibility and training, while unstructured interviews retain clinical nuance but require robust clinician training and documentation practices. Self-report instruments focused on anxiety and depression continue to act as frontline indicators, and their psychometric properties and cultural validity remain central to appropriate deployment.

Based on Paper-Based Tools, formats are typically either Checklist Formats or Questionnaire Forms, which continue to play a role in low-resource or face-to-face contexts where digital access is limited. Based on Wearable Screening Tools, the portfolio includes Biosensor Devices and Smart Watches, which enable physiological and behavioral signal capture for passive screening and ongoing monitoring. Across these segmentations, implementation considerations-such as interoperability, clinician acceptance, and validation against clinical outcomes-determine where and how each tool contributes to an effective screening strategy.

Regional adoption drivers and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape localization, validation, and deployment strategies

Regional dynamics materially influence adoption paths, regulation, and commercialization strategies. In the Americas, mature health system infrastructures, greater reimbursement clarity for digital health services, and well-established clinical networks have supported rapid integration of digital screening tools into primary care and specialist workflows. Investment in interoperability and large-scale pilot programs has stimulated collaboration between vendors and health systems, while privacy and data protection standards continue to evolve to balance innovation with patient rights.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varied health system maturity require adaptive strategies. Parts of Europe exhibit comprehensive regulatory frameworks and a strong emphasis on clinical validation and data protection, driving higher expectations for evidence generation. Meanwhile, markets in the Middle East and Africa present both challenges and opportunities: regulatory modernization and targeted public-private partnerships are expanding access, yet infrastructure variability and workforce constraints necessitate solutions tailored to local contexts and resource realities.

In the Asia-Pacific region, rapid digital adoption, high smartphone penetration, and significant investments in telehealth infrastructure create fertile ground for mobile-first screening solutions and scalable digital platforms. Diverse language needs and cultural norms underscore the importance of localized content, culturally validated instruments, and language-specific natural language processing models. Across all regions, aligning product strategies to local regulatory expectations, interoperability standards, and cultural considerations remains essential for sustainable deployment and meaningful clinical impact.

How cross-disciplinary technology vendors, device makers, clinical research centers, and strategic partners are shaping validation standards, integration pathways, and adoption momentum

Key corporate players and institutional contributors shape the innovation cadence and standards within the mental health screening domain. Technology providers specializing in AI and mobile development are accelerating capabilities around adaptive assessment, conversational interfaces, and secure data pipelines. Device manufacturers are refining sensor accuracy and energy efficiency to support passive monitoring, while clinical services and academic centers continue to generate validation evidence and best practices that underpin clinical acceptance.

Collaborations between software vendors and clinical networks are increasingly common, enabling iterative refinement of screening instruments and care pathways. Strategic partnerships with payer organizations and health systems have also evolved to demonstrate clinical utility and operational feasibility in real-world settings. Meanwhile, regulatory specialists and standards bodies are influencing product roadmaps by clarifying evidence expectations, privacy safeguards, and interoperability requirements.

Across the ecosystem, successful organizations exhibit capabilities in cross-disciplinary collaboration, rigorous clinical validation, and scalable technology deployment. They invest in explainable machine learning, robust security engineering, and clinician-facing workflows that reduce administrative burden. By prioritizing these competencies, industry participants position themselves to meet heightened expectations for reliability, accountability, and measurable clinical impact.

Actionable strategic priorities for leaders to move validated screening innovations into scalable, interoperable, and culturally adapted care pathways with robust governance

Industry leaders aiming to translate screening innovations into sustained impact should prioritize an integrated set of strategic actions. First, invest in rigorous clinical validation and transparent model governance to ensure tools perform reliably across diverse populations; this includes prospective validation studies and attention to bias mitigation. Second, design for interoperability from the outset to enable seamless integration with electronic health records and care management platforms, thereby embedding screening outputs into clinical decision-making and referral workflows.

Third, pursue localization and cultural adaptation for content and conversational interfaces to increase engagement and validity in different regions and languages. Fourth, adopt privacy-forward architectures and data minimization strategies that align with evolving regulatory expectations and strengthen user trust. Fifth, diversify supply chains and consider regional manufacturing or assembly options for device-dependent products to reduce exposure to trade disruption and accelerate delivery timelines.

Finally, cultivate partnerships with clinician groups, payers, and public health organizations to establish pragmatic implementation pathways. By combining robust evidence generation, technical interoperability, responsible data practices, and strategic partnerships, organizations can move from promising pilots to scalable, sustainable screening solutions that meaningfully improve pathways to care.

A rigorous mixed-methods research framework combining stakeholder interviews, technical assessment, and literature synthesis to produce actionable and reproducible insights

This research employs a mixed-methods approach that synthesizes primary stakeholder engagement with secondary literature analysis to produce a balanced and actionable perspective. Primary inputs include structured interviews with clinicians, technology developers, device manufacturers, and procurement leaders to capture operational realities, pain points, and adoption drivers. These qualitative engagements inform thematic analysis and the identification of best practices and implementation barriers.

Secondary inputs encompass peer-reviewed literature, regulatory guidance documents, standards publications, and relevant technical specifications to ensure that the analysis reflects current evidence and compliance expectations. Where appropriate, technical evaluations of algorithmic explainability, sensor fidelity, and interoperability protocols have been incorporated to assess maturity and implementation readiness. Triangulation across data sources supports credibility and reduces the risk of single-source bias.

Throughout the methodology, emphasis is placed on transparency, reproducibility, and defensible inference. Limitations are acknowledged, including the evolving nature of regulatory frameworks and the heterogeneity of regional operational contexts, which can affect generalizability. The approach therefore prioritizes actionable insights and strategic implications while noting areas where additional localized investigation is advisable.

A decisive synthesis that highlights the imperative to pair innovation with validation, governance, and regional strategy to translate screening advances into real clinical benefit

In conclusion, mental health screening is at an inflection point driven by digital capabilities, regulatory maturation, and evolving clinical workflows. The field has moved beyond singular instruments toward ecosystems that blend AI-enabled assessments, mobile engagement, clinician-guided evaluation, and passive monitoring. These integrated approaches offer the promise of earlier identification and more personalized pathways to care, but they also require rigorous validation, responsible data governance, and thoughtfully designed implementation strategies.

Stakeholders must therefore balance innovation with accountability by investing in evidence generation, interoperability, and culturally informed design. Supply chain resilience and regional strategy will continue to influence the availability and deployment timelines for device-dependent solutions, while evolving privacy and regulatory expectations will shape product roadmaps and commercialization strategies. By aligning technological capabilities with clinical needs and system constraints, organizations can convert screening advances into sustainable improvements in access and outcomes.

Ultimately, the path forward depends on collaborative ecosystems that prioritize reproducible results, clinician engagement, and patient-centered design, thereby ensuring that screening tools contribute meaningfully to efficient, equitable, and effective mental health care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mental Health Screening Market, by Digital Screening Tools

  • 8.1. AI-Powered Tools
    • 8.1.1. Machine Learning Models
    • 8.1.2. Nlp Chatbots
  • 8.2. Mobile Applications
    • 8.2.1. Hybrid Apps
    • 8.2.2. Native Apps
  • 8.3. Web Platforms

9. Mental Health Screening Market, by Clinical Screening Tools

  • 9.1. Clinician Interview
    • 9.1.1. Structured Interviews
    • 9.1.2. Unstructured Interviews
  • 9.2. Self-Report Questionnaire
    • 9.2.1. Anxiety Questionnaires
    • 9.2.2. Depression Questionnaires

10. Mental Health Screening Market, by Paper-Based Tools

  • 10.1. Checklist Formats
  • 10.2. Questionnaire Forms

11. Mental Health Screening Market, by Wearable Screening Tools

  • 11.1. Biosensor Devices
  • 11.2. Smart Watches

12. Mental Health Screening Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Mental Health Screening Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Mental Health Screening Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Mental Health Screening Market

16. China Mental Health Screening Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AbleTo, Inc.
  • 17.6. Happify Health, Inc.
  • 17.7. Headspace Health, Inc.
  • 17.8. Lyra Health, Inc.
  • 17.9. Modern Health, Inc.
  • 17.10. NeuroFlow Holdings, Inc.
  • 17.11. Quartet Health, Inc.
  • 17.12. SilverCloud Health Limited
  • 17.13. Spring Health, Inc.
  • 17.14. Talkspace, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MENTAL HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MENTAL HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 148. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 174. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 177. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 183. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 184. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 185. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 186. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)